IMMUNEXT INC.

Patent Applications and Registrations

Patent applications and USPTO patent grants for IMMUNEXT INC..The latest application filed is for "anti-human vista antibodies and use thereof".

Company Profile

8.4.19

IMMUNEXT INC. - LEBANON NH US
ImmuNext, Inc - Lebanon NH US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-human Vista Antibodies And Use Thereof App 20220259310 - MOLLOY; Michael ; et al.	2022-08-18
Anti-human Vista Antibodies And Use Thereof App 20210317207 - NOELLE; Randolph J. ; et al.	2021-10-14
Anti-human Vista Antibodies And Use Thereof App 20210317206 - MOLLOY; Michael ; et al.	2021-10-14
Anti-cd154 Antibody Having Improved Binding, Functional And Safety Characteristics And Use In Human Immunotherapy App 20210145966 - Rothstein; Jay ; et al.	2021-05-20
Anti-human Vista Antibodies And Use Thereof App 20210017281 - MOLLOY; Michael ; et al.	2021-01-21
Anti-CD154 antibody having improved binding, functional and safety characteristics Grant 10,874,738 - Rothstein , et al. December 29, 2	2020-12-29
Identification Of Vsig8 As The Putative Vista Receptor (v-r) And Use Thereof To Produce Vista/vsig8 Agonists And Antagonists App 20200199254 - Molloy; Michael ; et al.	2020-06-25
Anti-vista Antibodies And Fragments App 20200017589 - Snyder; Linda ; et al.	2020-01-16
Anti-human Vista Antibodies And Use Thereof App 20190330349 - MOLLOY; Michael ; et al.	2019-10-31
Anti-mct1 Antibodies And Uses Thereof App 20190263931 - Rothstein; Jay L. ; et al.	2019-08-29
Identification of VSIG8 as the putative VISTA receptor (V-R) and use thereof to produce VISTA/VSIG8 agonists and antagonists Grant 10,370,455 - Molloy , et al.	2019-08-06
Anti-cd154 Antibody Having Improved Binding, Functional And Safety Characteristics And Use In Human Immunotherapy App 20180193454 - Rothstein; Jay ; et al.	2018-07-12
Anti-human Vista Antibodies And Use Thereof App 20180079811 - MOLLOY; Michael ; et al.	2018-03-22
Anti-human Vista Antibodies And Use Thereof App 20170306021 - MOLLOY; Michael ; et al.	2017-10-26
Anti-human Vista Antibodies And Use Thereof App 20170306023 - LEMERCIER; Isabelle ; et al.	2017-10-26
Anti-human Vista Antibodies And Use Thereof App 20170306019 - CARRIERE; Catherine ; et al.	2017-10-26
Anti-human Vista Antibodies And Use Thereof App 20170306024 - NOELLE; Randolph J. ; et al.	2017-10-26
Anti-human Vista Antibodies And Use Thereof App 20170306020 - NOELLE; Randolph J. ; et al.	2017-10-26
Anti-human Vista Antibodies And Use Thereof App 20170306022 - MOLLOY; Michael ; et al.	2017-10-26
Use Of Vista Agonists And Antagonists To Suppress Or Enhance Humoral Immunity App 20170119877 - GREEN; Kathy A. ; et al.	2017-05-04
Identification Of Vsig8 As The Putative Vista Receptor (v-r) And Use Thereof To Produce Vista/vsig8 Agonists And Antagonists App 20160159927 - Molloy; Michael ; et al.	2016-06-09

Company Registrations

NCAGE Code	6BYC6	IMMUNEXT, INC.
CAGE Code	6BYC6	IMMUNEXT, INC.
S.A.M. Registration	6BYC6 [967719241]	IMMUNEXT, INC.
DUNS	967719241	IMMUNEXT, INC.

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.